Columbia Pacific Advisors’ Business Finance strategy (CPBF), a Seattle-based fund which makes debt and structured equity investments in privately-held and sponsor backed companies, celebrated its three year anniversary of business operations.
“CPBF marks its third anniversary with gathering momentum. We are honored to work with dynamic founders and other entrepreneurial business leaders who choose to partner with CPBF to finance value-creating strategic initiatives,” said Trent Stedman, Managing Director of CPBF. “Our team’s diverse and deep experience and solutions-oriented approach have enabled shareholders of privately held middle market companies to generate gains of more than $350 million in this short time, through minimally-dilutive financings for acquisitions, organic growth initiatives, and balance sheet repositionings.”
Since launching in 2019, CPBF has provided financing solutions across 13 transactions in eight states and deployed over $250 million. CPBF led the origination and structuring of all loans which range in size from $7 million to $30 million. Additionally, over 85 percent of the total loans have been provided to privately-held companies.
CPBF has deployed capital in various industries including electronics, gaming, healthcare, HVAC, logistics, payments, semiconductor, B2B software, and waste management. A few transaction highlights include:
- The successful exit of FragilePAK, which utilized a $16 million debt investment to grow their last-mile delivery service ahead of its successful sale to Greenbriar Equity Group.
- A $17 million debt investment and equity backstop for Portland-based independent sponsor, Bridgehouse Capital, to support their acquisition of Signal Hound.
- Increased Triad Semiconductor’s facility from $16 million to $23 million to support their continued development of innovative analog chipsets for AR/VR, medical devices, and networking products.
- A $30 million delayed draw term loan to Sight Partners, a Washington-based, doctor-led MSO pursuing a regional consolidation strategy in ophthalmology.
